Radiation induced angiosarcoma of the breast: outcomes from a retrospective case series
Open Access
- 7 August 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical Sarcoma Research
- Vol. 7 (1), 1-6
- https://doi.org/10.1186/s13569-017-0081-7
Abstract
Radiation induced angiosarcoma (RIAS) of the breast is a rare and aggressive complication of radiotherapy. Due to the rarity of this disease, much of the evidence for its management is based on case reports or small retrospective series. We sought to describe the management and outcomes of RIAS in a large single-institution series. All patients diagnosed with RIAS between January 2000 and January 2014 were identified from an institutional database. A total of 49 patients were identified. Median age at diagnosis was 72 years (range 51–93). Median time from completion of radiotherapy to diagnosis of RIAS was 7.5 years. Median tumour size at presentation was 5.0 cm (1.5–19.0). The majority of patients presented with localised disease (47, 95.9%). Of these, 35 (74.5%) were suitable for surgery and underwent surgery with curative intent. Twelve patients presented with localised irresectable disease. Of these, 7 received systemic chemotherapy, with a sufficient response to facilitate surgery in 3 patients. Following potentially curative surgery, 2-year local recurrence-free was 55.2%. Survival was significantly prolonged in patients presenting with resectable disease (2-year overall survival 71.1% vs 33.3%, p < 0.001). Tumour size >5 cm was prognostic of distant metastases-free survival and overall survival. RIAS are rare, aggressive soft-tissue lesions with limited treatment options and high-rates of both local and systemic relapse.Keywords
This publication has 23 references indexed in Scilit:
- Thalidomide Combined with Neoadjuvant Chemotherapy in Angiosarcoma of the Breast with Complete Pathologic Response: Case Report and Review of LiteratureBreast Care, 2013
- Radiation-Associated Angiosarcoma After Breast Cancer: High Recurrence Rate and Poor Survival Despite Surgical Treatment with R0 ResectionAnnals of Surgical Oncology, 2012
- Radiation-Induced Sarcoma of the Breast: A Systematic ReviewThe Oncologist, 2012
- Surgical management of radiation-associated cutaneous breast angiosarcomaJournal of Plastic, Reconstructive & Aesthetic Surgery, 2011
- Surgical management of radiation-induced angiosarcoma after breast conservation therapyThe American Journal of Surgery, 2011
- AngiosarcomaThe Lancet Oncology, 2010
- Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wallBreast Cancer Research and Treatment, 2010
- Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX StudyJournal of Clinical Oncology, 2008
- Risk of Angiosarcoma Following Breast Conservation: A Clinical AlertThe Breast Journal, 2005
- Angiosarcoma after breast‐conserving therapyCancer, 2003